Recent Finacing
Recent Raise
NEOGAP Therapeutics is a Swedish biotech company developing personalised T-cell–based immunotherapies for solid tumours, starting with advanced colorectal cancer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at NEOGAP Therapeutics.
